LICENCIAS OBLIGATORIAS POR RAZONES DE SALUD PúBLICA EN CHILE: UN ANáLISIS COMPARATIVO CON EL ACUERDO SOBRE LOS ADPIC

in implementing its various international agreements on intellectual property, chile has amended its industrial property act, which regulates the patent system, by recognizing the patentability of pharmaceutical products (1991) and establishing a scheme for granting compulsory licenses based on reasons of public health (2005). this article describes and analyses the rules adopted about compulsory licenses on pharmaceutical patents in order to establish whether it meets the standard promoted by the world trade organization in the agreement on trade related aspects of intellectual property rights (trips) and takes advantages of flexibilities provided by international agreements, especially those resulting of the doha declaration.